MedPath

VYXEOS LIPOSOMAL 44 MG/100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

VYXEOS LIPOSOMAL 44 MG/100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1181308001

Prescription Type

Uso Hospitalario

Authorization Date

Dec 18, 2018

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181308001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

CITARABINAActive
Quantity: 100 mg
Name: CITARABINA
DAUNORUBICINA HIDROCLORUROActive
Quantity: 44 mg
Name: DAUNORUBICINA HIDROCLORURO

ATC CLASSIFICATION (3)

L01X
L01XY
L01XY01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.